CUTANEOUS VASCULITIS. Katharine Warburton ST6 Dermatology

Similar documents
PAEDIATRIC VASCULITIS

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth

Small Vessel Vasculitis

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

VASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018

Henoch-Schonlein Purpura Guidelines

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Henoch Schonlein Purpura

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT

VASCULITIS. Case Presentation. Case Presentation

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected

ANCA associated vasculitis in China

Dr. Rai Muhammad Asghar Head of Paediatric Department BBH Rawalpindi

FAQ Identifying and enrolling participants

RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018

The Vasculitis Syndromes

Managing Acute Medical Problems, Birmingham Vasculitis. David Jayne. University of Cambridge

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Atlas of the Vasculitic Syndromes

Small Vessel Vasculitis

Joint Trust Guideline for the Management of: Henoch Schönlein Purpura (HSP) in Children

Case conference. Welcome Dr. Lawrence Tierney

RAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident

Year 2004 Paper one: Questions supplied by Megan

Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant

A. Smržová. III. Interní klinika FN Olomouc nefrologická, revmatologická a endokrinologická

Vasculitis and the Dermatologist: General approach, pitfalls, and pearls

CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation)

AN APPROACH TO HEMATURIA. Dr Saima Ali

A number of factors point to the likelihood of a person with RA developing RV:

a mimicker of Wegener s Granulomatosis

*HSP is a common vasculitis of small vessels with cutaneous & systemic complications. Its etiology is unknown& often follows URTIs.

Vasculitis. Marwan Adwan. 4 th year MBBS. Consultant Rheumatologist. MBChB, MRCPI, MSc, MRCP (rheum)

GRANULOMATOSIS WITH POLYANGIITIS

Dr P Sigwadi 30 May 2012

Children & Young People s Directorate. Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

KAWASAKI DISEASE. What is Kawasaki disease? Causes

Five things not to miss in Dermatology. Dr Judy Wismer Associate Clinical Professor Michael G DeGroote School of Medicine

HENOCH SCHÖNLEIN PURPURA (VASCULAR PURPURA, ANAPHYLACTOID PURPURA) IN CHILDREN Single choice tests (SC)

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London

29 Glomerular disease: an overview

Done by: Shatha Khtoum

CENTRAL NERVOUS SYSTEM VASCULITIS

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Glomerular pathology in systemic disease

Rituximab treatment for ANCA-associated vasculitis in childhood

CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS

Disclaimer. This is a broad survey and cannot cover all differential diagnoses or each condition in thorough detail

Clinical Case Conference Tuesday August 25, 2015 Dana Assis, MD

Jones slide di 23

The histological assessment of cutaneous vasculitis

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Diagnostic Procedures for Vasculitis

Vasculitis local: systemic

Rheumatology Primer: What Labs and When

A clinical syndrome, composed mainly of:

LRI Children s Hospital

ANCA+ VASCULITIDES CYCAZAREM,

Immune-mediated lung disease. Ian Sabroe

Index. Note: Page numbers of article titles are in boldface type.

Direct immunofluorescence testing in vasculitis A single institution experience with Henoch-Schönlein purpura

Scleritis LEN V KOH OD

ARTHRITIS FOUNDATION VASCULITIS

EUVAS update June 5 th Marinka Twilt

GPA & MPA GRANULOMATOSIS WITH POLYANGIITIS &MICROSCOPIC POLYANGIITIS. What you need to know about GPA & MPA

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)

vasculitis Patomorfologia vasculitis (arteritis) caused by infections vasculitis (arteritis) caused by infections

Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome.

Familial Mediterranean Fever

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

Henoch-Schӧnlein Purpura (HSP) Child Health Patient Information Leaflet

TREATMENT OF ANCA-ASSOCIATED VASCULITIS

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

Childhood nephrotic syndrome practice guidelines

Henoch-Schonlein Purpura (HSP)

CIC Edizioni Internazionali. Cutaneous vasculitides and vasculopathies. Review. Giampiero Girolomoni Paolo Rosina. severity.

Vasculitis. Seth Mark Berney, MD Professor of Medicine Chief, Division of Rheumatology University of Arkansas for Medical Sciences

HSP nephritis: when should you refer to a Nephrologist?

Secondary IgA Nephropathy & HSP

ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS. Myriam Farah, MD, FRCPC

Cellulitis: a practical guide

Plan. Sarcoidosis 21/07/2017. Sarcoidosis Liver involvement. Sarcoidosis GI involvement. Sarcoidosis Diagnosis

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases

A TRICKY PROBLEM. Presenter-Dr Lakshmi PK

Luke Droney IMMUNOGLOBULIN LEVELS AND FUNCTION

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Case Report. 15th June Carolina Ourique Luciana Frade Daniela Alves

Crescentic Glomerulonephritis (RPGN)

Case Presentation. Rafid Asfar, MD

Shawkat Michel, M.D.

Transcription:

CUTANEOUS VASCULITIS Katharine Warburton ST6 Dermatology

AIMS Clinical cases introduction The theory Categorising cutaneous vasculitis Features presenting in the skin Mimics/pitfalls How to initially manage and investigate in GIM When to involve dermatology When is biopsy required Management principles Back to cases

CASES

CASE 1 57 year old female Mild chronic ITP, untreated (plts 80) Obesity Had 3/7 trimethoprim from GP for uncomplicated UTI Completed 12 days ago Presents with new rash after travelling up from Cornwall Well Obs normal Urine dip normal Initial bloods ok

CASE 2 22 year old student Rapidly extending rash 1 wk GP gave antibiotics for folliculitis but progressed Feels not right, bit achey. Crampy abdo pain. BP 132/75 Urine dip trace of protein Initial bloods ok, vasculitis screen pending

CASE 3 Female, 54 Acute presentation ascites, leg swelling, vomiting Hep C positivity identified Perforated gastric ulcer, multi organ failure

THE THEORY Vasculitis = inflammation of blood vessel

CLASSIFYING VASCULITIS Small vessels <50micrometers Medium vessels 50-150 micrometer Large vessel

CATEGORISING CUTANEOUS VASCULITIS Reactive/secondary IgA vasculitis (Henoch-Schonlein Purpura, HSP) Urticarial vasculitis Cryoglobulinaemic ANCA associated Polyarteritis nodosa Primary systemic vasculitidies (<4%) Nodular

CATEGORISING CUTANEOUS VASCULITIS Reactive/secondary (cutaneous small vessel vasculitis) Mostly limited to skin 7-10 days after exposure to enticing agent Longer (7-21 days) for drugs IgA vasculitis (Henoch-Schonlein Purpura, HSP) Urticarial vasculitis Causes 15% infection 15% drugs 10% inflammatory/connective tissue disorder 5% cancer 50% unknown Exercise induced Cryoglobulinaemic ANCA associated Polyarteritis nodosa Nodular

CATEGORISING CUTANEOUS VASCULITIS IgA vasculitis (Henoch-Schonlein Purpura, HSP) Children/younger adults Post strep Purpuric rash (to buttocks) Joint and abdominal pain IgA nephropathy

CATEGORISING CUTANEOUS VASCULITIS Urticarial vasculitis Nettle rash / hives / urticaria, lesions last longer than 24hours Leaves brown pigment 50% unknown cause SLE, malignancy, viral infections, medications Complement levels helpful for catergorising Manage in OP dermatology, unless concerning features

CATEGORISING CUTANEOUS VASCULITIS Cryoglobulinaemic Immunoglobulins soluble in blood but precipitate at lower temperatures skin, kidneys, nervous system Types I - Heam malignacies II lymphoproliferative disorders III (and II) Rheumatoid disease, infections Hep C infection 90% Testing: immunology Lab LGI Beware digital ischaemia Treat underlying disease

CATEGORISING CUTANEOUS VASCULITIS Reactive/secondary Microscopic IgA polyangiitis vasculitis (Henoch-Schonlein granulomatosis with Purpura, HSP) Urticarial vasculitis Cryoglobulinaemic ANCA associated Polyarteritis nodosa Nodular Eosinophilic polyangitis (syn CSS) Granulomatosis with polyangiitis (syn. Wegner s) panca (MPO) in 60-80% panca (MPO) in 50-80% canca (PR3) in 90% - 70-90% necrotizing glomerulonephritis - 25-50% respiratory complications Constitutional symptoms common for all - Asthma - Eosinophilia - Necrotizing vasculitis with extravascular granulomas 3 stages Skin findings usually palpable purpura. Rarely nodules, ulcers, digital ischaemia, livedo. - 50% - 70% - 40% Triad: - Vasculitis - 80% Necrotizing granulomas respiratory tract - 75% glomerulonephritis

CATEGORISING CUTANEOUS VASCULITIS Polyarteritis nodosa Medium vessel: skin = nodules, ulcers, livedo Cutaneous PAN mostly just skin relapsing remitting constitutional upset Systemic PAN Multiorgan Skin, kidney, GI, neuro, cardiac Chronic, insidious raised ESR, hypertension ACR 1990 Classification May or may not involve skin Hep B link (30% cases) Deep biopsy helpful Aggressive treatmnet cyclophosphamide, IVIg

CATEGORISING CUTANEOUS VASCULITIS Nodular Medium vessels nodules, ulcers, oedema Usually lower legs (calves), also thighs, arms?result of slowed circulation Casues panniulitis ie inflammation of the fat Can be a sign of TB

RELEVANT FINDINGS IN THE SKIN Petichiae, Purpura Palpable Purpura, Haemorrhagic Bullae

RELEVANT FINDINGS IN THE SKIN Purpura, Haemorrhagic bullae, ulceration

RELEVANT FINDINGS IN THE SKIN

RELEVANT FINDINGS IN THE SKIN Vasculitic nodules (can ulcerate) Livedo

RELEVANT FINDINGS IN THE SKIN Urticarial vasculitis urticaria and hyperpigmentation

RELEVANT FINDINGS IN THE SKIN Resolving vasculitis Red purple brown

PITFALLS/MIMICS Capillaritis Leaky vessels (stasis/pressure) Platelet disorders, anticoagulated

PITFALLS/MIMICS Vaso-occlusive disorders hypercoaguable states, thrombosis, emboli (eg cholesterol, septic).

PITFALLS/MIMICS Scurvy

INITIAL MANAGEMENT IN GIM

INITIAL MANAGEMENT APPROACH IN GIM 3 key questions: Is there systemic involvement? Is there an obvious cause? How severe is this?

APPROACH: SYSTEMIC INVOLVEMENT? THINK: renal, GI, lung, neuro Thorough review of systems and full examination Lymphadenopathy Fever, BP Urine dip and PCR FBC, U&E, LFT, ESR, CRP Radiology eg CXR

APPROACH: CAUSE? Any new meds? Recent illness? Travel and sexual history Relevant PMH

APPROACH: CAUSE? ANCA ANA c3/4 (if low complement consider cryoglobulins, anti-cq1, anti APS) RhF Immunoglobulins TOP TIP!! Serum electrophoresis, BJP ICE > Adult services A-I ASOT > Dermatology > vasculitis screen Viral serology eg EBV Hep B/C, HIV Consider skin biopsy, malignancy screen

APPROACH: SEVERITY Skin compromise? Ulceration Digit ischaemia

Worried - Unwell patient - Systemic features - Odd sites (not just acral) - Nodular/ ulcerating/ blistering - Ischaemia of extremities Not too worried - Well patient - Screening normal - Obvious trigger - Flat rash, starting to resolve (turning brown)

DERMATOLOGY INPUT Threat to tissue/severe Needs active treatment Biopsy requirements less so if uncomplicated cutaenous vasculitis with obvious cause Helpful and accessible if thinking systemic vasculitis, vaso-occlusive Pictures and full history please!!

MANAGEMENT PRINCIPLES

TREATMENT PRINCIPLES If systemic involvement involve relevant specialty Treat a cause Eg infection, withdraw causative drugs etc

IF SKIN INVOLVEMENT ONLY Mild Mostly supportive grade 1 compression stockings ibuprofen Leg elevation and rest 90% self resolve Voltaire: The art of medicine consists of amusing the patient while nature cures the disease Ensure urine dips weekly one month minimum Mod/severe Control (pred, IVMP, AZA, CyA, MTX) Maintain remission (MTX, AZA, MMF, pred, rituximab)

BACK TO THE CASES

SUMMARY

IN SUMMARY Don t panic, often well patients don t need admission or instant dermatology input Exclude systemic involvemnt first Think of causes Assess severity Pictures extremely helpful for discussions Thank you any questions?